FAGRON SERVICES NORTHERN EUROPE SP Z O O
Location
małopolskie
Founded
2018-08-20
Website
Risk Signals
225 news mentions monitored
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Food Preparations, Not Elsewhere Classified, Pharmaceutical Preparations, Perfumes, Cosmetics, and Other Toilet Preparations, Adhesives and Sealants, Explosives, Chemicals and Chemical Preparations, Not Elsewhere Classified), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about FAGRON SERVICES NORTHERN EUROPE SP Z O O
Live alerts from global media, monitored by Business Radar
2025-03-07 (taiwannews.com.tw)
Fagron publishes its annual report 2024 | Taiwan News | Mar. 6, 2025 14:00
Regulated information – inside information
Read more
2025-03-06 (iex.nl)
Fagron publishes Annual Report 2024
Regulated information - Prevention Nazareth (Belgium)/Rotterdam (the Netherlands), March 6, 2025 - 7 am CET
Read more
2025-02-28 (beursduivel.be)
Fagron is growing strongly on its own and through acquisitions | Stock exchange devil premium
A week ago, drug -maker Fagron handed very solid annual figures that were narrowly better than expected. The dividend is also a bit higher. Management sounds optimistic.
Read more
2025-02-16 (knack.be)
A preview: what is waiting for us this week for the fair? -
1/ Results Aedifica Agevreldaard In the coming days, the results of EVS (Tuesday after the exhibition), Ontex (Wednesday), Fagron (Thursday) and Cofinimmo are
Read more
2025-01-20 (deaandeelhouder.be)
Stock market view: Kepler Cheuvreux puts Fagron on the buying list
Kepler Cheuvreux has increased the recommendation for Fagron to Buy and the price target from 19.50 to 20.75 euros, prior to the annual figures. This emerged from an analyst report on Monday. The analysts expect organic sales growth of 11.8 percent, an adjusted EBTDA result of 173 million euros and a net debt of 272 million euros. After conversations with
Read more
2025-01-08 (beursduivel.be)
Kepler Cheuvreux puts Fagron on the purchase list
Kepler Cheuvreux has increased the recommendation for Fagron to Buy and the price target from 19.50 to 20.75 euros, prior to the annual figures. This emerged from an analyst report on Monday.
Read more
2024-10-22 (beleggersbelangen.nl)
Fagron | Pharmaceutical company maintains growth rate
Fagron once again achieved a turnover figure in the third quarter that exceeded expectations. Once again it was insufficient for a price breakout.
Read more
2024-10-12 (deaandeelhouder.nl)
Fagron is back on track
Fagron: back on the right track Good turnover growth after 9 months The US remains an important growth engine Margin improvement expected this year Fagron yesterday provided an update on the third quarter.
Read more
2024-10-10 (iex.nl)
Stock exchange view: impressive growth again at Fagron
Fagron once again showed impressive growth in the past quarter. Degroof Petercam concluded this on Thursday in response to the figures from the master preparer.
Read more
2024-10-10 (thefinancialanalyst.net)
Fagron Reports 12.1% Revenue Growth in Q3 2024, Boosting Market Confidence
Fagron, a global leader in the pharmaceutical compounding sector, reported a robust third quarter for 2024, showcasing a revenue growth of 12.1%.
Read more
2024-10-10 (iex.nl)
Stock exchange view: Fagron exceeds expectations
Fagron exceeded turnover expectations in the third quarter. Kepler Cheuvreux analysts concluded this in a report on Thursday.
Read more
2024-10-10 (iex.nl)
Fagron turnover growth continues
Fagron recorded higher turnover in the third quarter of this year and maintained the outlook for the whole of 2024. This was evident from figures from the pharmaceutical compounder on Thursday.
Read more